Article

Survey: Computer users laud near variable focus lenses

Near-variable focus (NVF) lenses for computer use are overwhelmingly favored over progressive lenses, according to a comparison survey conducted in four regions of the United States.

Near-variable focus (NVF) lenses for computer use are overwhelmingly favored over progressive lenses, according to a comparison survey conducted in four regions of the United States.

The survey, conducted by PRIO Corp., included current wearers of premium progressive lenses who spend a minimum of 3 hours daily at a computer and fitted them with NVF lenses.

The following results were reported:

  • 81% preferred NVF lenses.

  • 19% preferred progressive addition lenses (PALs).

  • 84% experienced the lowest level of computer eyestrain with the NVF glasses.

  • 86% reported the best clarity with NVF lenses.

  • 89% said they had less head movement with NVF lenses.

PRIO collected and analyzed the results of three surveys given to 40 computer-using subjects.

"We chose to conduct the survey because of the perception by many eye-care professionals and consumers that progressive lenses are a good choice for viewing a computer screen," said Jon Torrey, PRIO president and chief executive officer, in a company statement. "The data reported by subjects in this survey showed that NVF lenses are a much better choice in terms of comfort and clarity."

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) ASCRS 2025: Mark Lobanoff, MD, on making the move to office-based surgery
Barsha Lal, PhD, discusses the way low dose atropine affects accommodative amplitude and dynamics at the 2025 ARVO meeting
(Image credit: Ophthalmology Times) NeuroOp Guru: When eye findings should prompt neuroimaging in suspected neuro-Behcet disease
At the Association for Research in Vision and Ophthalmology (ARVO) meeting, Katherine Talcott, MD, a retina specialist at Cleveland Clinic, shared her findings on EYP-1901 (EyePoint Pharmaceuticals) in the phase 2 DAVIO study.
Dr. Jogin Desai, founder of Eyestem Research, discusses his research at the Association for Research in Vision and Ophthalmology.
(Image credit: Ophthalmology Times) ASCRS 2025: Michael Rivers, MD, shares his takeaways as a panelist at the inaugural SightLine event
(Image credit: Ophthalmology Times) ASCRS 2025: Karl Stonecipher, MD, on LASIK outcomes using an aspheric excimer laser for high myopia
John Tan talks about an emergency triage framework for retinal artery occlusion at the 2025 Association for Research in Vision and Ophthalmology (ARVO) meeting.
Dr Robert Maloney at the 2025 Controversies in Modern Eye Care meeting
Wendy Lee, MD, MS, at Controversies in Modern Eye Care 2025.
© 2025 MJH Life Sciences

All rights reserved.